There is also a growing problem with severe child obesity, data from the National Child Measurement Programme for England found. One in five children in year 6 were classified as obese in the ...
A person with Down syndrome may be more likely to develop obesity than someone without it. This is due to additional medical conditions and physiological factors, among other reasons. A person who ...
Here's a look at the latest research and promising results: After trying to address diabetes and obesity, GLP-1 studies have focused on CV risks and events. The SELECT trial found semaglutide ...
GLP-1 receptor agonists are revolutionizing health care, moving beyond diabetes and obesity to treat cardiovascular, kidney, and possibly neurodegenerative diseases. As usage expands and costs drop, ...
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity Date: October 25, 2024 Source: Brigham and Women's Hospital Summary: A new study has examined a large sample of ...
GLP-1s are being tested on patients with Alzheimer’s, on top of conditions that can often go hand-in-hand with obesity. For pharmaceutical companies that are (or want to be) big players in areas ...
Lilly's Mounjaro to cost 2,200 Danish crowns per month Wegovy's price ranges from 1,313 to 2,353 crowns per month Denmark's public health system does not reimburse weight-loss drugs The two ...
New precision medicine approach helps detect subgroups of people with obesity at high risk of diabetes and heart disease Date: October 24, 2024 Source: Lund University Summary: Obesity is a common ...
Discover stories from this section and more in the list of contents ...
The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as Wegovy. It follows reports of some people who are not obese becoming sick ...
HONG KONG, Oct 22 (Reuters) - China's National Health Commission (NHC) published its first set of guidelines to standardise the diagnosis and treatment of obesity, with more than half of China's ...